Actively Recruiting

Age: 60Years +
All Genders
Healthy Volunteers
ID07232667

Healthy Taiwan Cultivation Plan: Building an Active-ageing Lifestyle in Rural Taiwan Through Integrating Novel Healthcare Technology From Mitigating Digital and Health Literacy Gap to Exploring Multi-dimensional Digital Biomarkers of Ageing

Led by China Medical University Hospital · Updated on 2026-05-18

140

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

Sponsors

C

China Medical University Hospital

Lead Sponsor

M

Ministry of Health and Welfare, Taiwan

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are studying the health and digital literacy of older adults living in rural Taiwan, particularly in Yunlin County, an area facing high rates of chronic diseases, frailty, dementia, and lifestyle challenges. This observational study aims to develop a wearable and mobile health research framework to monitor physical activity, sleep, cognitive biomarkers, and digital skills to support healthy aging. The project aligns with Taiwan's Healthy Taiwan Cultivation Plan and seeks to establish a digital aging database and identify markers predicting cognitive and functional decline. Participants will use several digital tools including a research-grade wrist actigraphy device (GeneActiv) to track activity and sleep for at least two weeks, the iMED mobile health app for personalized education and medication reminders, and an under-mattress sensor (iCue) for those with limited mobility. They will also attend educational sessions based on the World Health Organization's Integrated Care for Older People framework and provide blood samples to measure dementia-related biomarkers. The study will occur in two phases from 2025 to 2029, with initial baseline assessments followed by ongoing monitoring every three months. During the study, participants will undergo physical activity and sleep monitoring, cognitive and functional assessments using standardized questionnaires, and blood biomarker sampling at baseline and study end. Data collected will include wearable sensor information, clinical evaluations, and qualitative feedback on technology usability and user experience. The study aims to follow participants for up to 36 months, assessing changes in health behaviors, mental well-being, and functional status while developing a sustainable digital health model for rural older adults.

CONDITIONS

Brief Title

Digital Technology for Active and Healthy Ageing in Taiwan

Who Can Participate

Age: 60Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Currently living or receiving care in a stable environment for at least 4 weeks prior to enrollment
  • Resided at the same address for 4 or more weeks if community-based
  • Attended the same dementia or elderly day-care center for 4 or more weeks if day-care participant
  • Able and willing to participate in study procedures
  • Provided informed consent or legal representative consent if cognitive decline prevents self-consent
Not Eligible

You will not qualify if you...

  • Unstable physical or psychological condition that makes participation unsafe, such as acute delirium or current respiratory infection
  • Known allergy or skin sensitivity to materials used in the Geneactiv device or iCue sensor pad
  • Any other medical, neurological, or behavioral condition deemed unsuitable for participation by the study physician

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - At baseline

Participants provide baseline blood samples for dementia-related biomarker analysis and undergo standardized health and digital literacy assessments.

1 baseline visit (in-person)

Monitoring

Duration - At least 2 weeks initially, then ongoing through study

Participants wear a wrist actigraphy device for at least two weeks and may use an under-mattress sensor if mobility is limited, while using a mobile health app to track health and receive feedback.

Initial 2-week monitoring plus continued use; follow-up visits every 3 months

Outpatient Treatment

Duration - Ongoing throughout the study

Participants attend community-based educational sessions on physical activity, diet, cognitive health, and digital literacy adapted from the Aging Well Taiwan program based on WHO's ICOPE model.

Periodic community sessions

Long-term Monitoring

Duration - Up to 36 months

Participants are followed every three months to assess changes in activity, sleep, medication use, mental well-being, and behavioral outcomes, with repeat blood sampling at the end of the study.

Quarterly visits for assessments; blood samples at baseline and end of study

Trial Site Locations

Total: 1 location

1

China Medical University Beigang Hospital

London, Alabama, United Kingdom, WC1N 2AN

Actively Recruiting

Loading map...

Research Team

D

Dr Ta-Wei Guu Consultant psychiatrist, MD, PhD

Y

Yueh-Heng Chiang, RN, MS.

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

Absorption and Tolerability of Injectable Administration of ...

Healthy Aging

Actively Recruiting

1 location

Adopting a Health-social Partnership Program to Promote Heal...

Healthy Aging

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Wrist-worn actigraphy in agitated late-stage dementia patients: A feasibility study on digital inclusion.

Ta-Wei Guu, Anna-Katharine Brem, Christopher P Albertyn...

https://pubmed.ncbi.nlm.nih.gov/38497216